August 30, 2016 11:04 AM ET


Company Overview of Syndax Pharmaceuticals, Inc.

Key Executives for Syndax Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Briggs W. Morrison M.D.16 RelationshipsChief Executive Officer and Director56
Michael A. Metzger MBANo RelationshipsPresident and Chief Operating Officer45
Michael Downes Ph.D.No RelationshipsCo-Founder--
Ronald M. Evans Ph.D.60 RelationshipsCo-Founder, Advisor and Chair of Scientific Advisory Board--
Richard A. Heyman Ph.D.58 RelationshipsCo-Founder59
View More Key Executives

Syndax Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis G. Podlesak MBA 38 RelationshipsDomain Associates, L.L.C.58
Briggs W. Morrison M.D. 16 RelationshipsSyndax Pharmaceuticals, Inc.56
Ronald M. Evans Ph.D. 60 RelationshipsSyndax Pharmaceuticals, Inc.--
Kim Puloma Kamdar Ph.D. 101 RelationshipsSalveo DX, Inc.48
Luke B. Evnin Ph.D. 103 RelationshipsBlade Therapeutics, Inc.53
View All Board Members

Syndax Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Richard P. Shea16 Relationships3 Executives
Compensation Committee Ph.D.Luke B. Evnin103 Relationships3 Executives
Nominating Committee Ph.D.Kim Puloma Kamdar101 Relationships4 Executives
Corporate Governance Committee Ph.D.Kim Puloma Kamdar101 Relationships4 Executives
Advisory Board Ph.D.Ronald M. Evans60 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$373.4K
Compensation as of Fiscal Year 2015
Syndax Pharmaceuticals, Inc. CEO Compensation
Industry Average


Bone Therapeutics SA Appoints Benoît Champluvier as Chief Technology and Manufacturing Officer
August 30, 2016 5:00 AM ET
Adverum Biotechnologies, Inc. Announces Resignation of John P. McLaughlin as Member of the Board of Directors, Chairman and Member of the Audit Committee and Member of the Compensation and Nominating and Corporate Governance Committees of the Board, Effective as of August 31, 2016
August 29, 2016 8:44 PM ET
OncoCyte Corporation Announces Board Changes
August 29, 2016 8:15 PM ET
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes
August 29, 2016 12:51 PM ET
FORMA Therapeutics, Inc. Appoints Karoline Shair as Vice President, Legal and Chief Intellectual Property Counsel
August 29, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Syndax Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at